Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients
Status:
Completed
Trial end date:
2017-12-21
Target enrollment:
Participant gender:
Summary
The purpose of the study is to prove equivalence of efficacy and safety of BCD-066 and
Aranesp® in treatment of anemia in end-stage chronic kidney disease patients on dialysis.